Description
Gliclazideisasulfonylureacompoundthatinhibitssulfonylurea1(SUR1)receptors,exhibitinganti-diabeticandantioxidativeactivities.InhibitionofthesereceptorsclosesK+ionchannels,inducingcellmembranedepolarization,alteringCa2+homeostasis,andstimulatinginsulinrelease.Invitro,gliclazideinhibitsH2O2-inducedmitochondrialdamageandapoptosis,decreasingoxidativestress.
References
ProksP,deWetH,AshcroftFM.MolecularmechanismofsulphonylureablockofK(ATP)channelscarryingmutationsthatimpairATPinhibitionandcauseneonataldiabetes.Diabetes.2013Nov;62(11):3909-19.PMID:23835339.
SliwinskaA,RogalskaA,SzwedM,etal.Gliclazidemayhaveanantiapoptoticeffectrelatedtoitsantioxidantpropertiesinhumannormalandcancercells.MolBiolRep.2012May;39(5):5253-67.PMID:22183301.
LawrenceCL,ProksP,RodrigoGC,etal.Gliclazideproduceshigh-affinityblockofKATPchannelsinmouseisolatedpancreaticbetacellsbutnotratheartorarterialsmoothmusclecells.Diabetologia.2001Aug;44(8):1019-25.PMID:11484080.